15 Einträge gefunden

1. Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer

   1. Steurer, Stefan
   2. Hager, Benjamin
   3. Büscheck, Franziska
   4. Höflmayer, Doris
   5. Tsourlakis, Maria Christina
   6. Minner, Sarah
   7. Clauditz, Till S

   2019 - Forschungsinformationssystem des UKE
2. Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues

   1. Kind, Simon
   2. Merenkow, Christina
   3. Büscheck, Franziska
   4. Möller, Katharina
   5. Dum, David
   6. Chirico, Viktoria
   7. Luebke, Andreas M

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
3. Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

   1. Schroeder, Cornelia
   2. Grell, Jan
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Lang, Dagmar
   6. Simon, Ronald
   7. Höflmayer, Doris

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
4. A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer

   1. Kind, Simon
   2. Jaretzke, Annika
   3. Büscheck, Franziska
   4. Möller, Katharina
   5. Dum, David
   6. Höflmayer, Doris
   7. Hinsch, Andrea

   2019 - Forschungsinformationssystem des UKE
5. High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

   1. Weidemann, Sören A
   2. Sauer, Charlotte
   3. Luebke, Andreas M
   4. Möller-Koop, Christina
   5. Steurer, Stefan
   6. Hube-Magg, Claudia
   7. Büscheck, Franziska

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
6. A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

   1. Eichenauer, Till
   2. Hussein, Mohammad
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Büscheck, Franziska
   6. Höflmayer, Doris
   7. Tsourlakis, Maria Christina

   2019 - Forschungsinformationssystem des UKE
7. The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

   1. Büscheck, Franziska
   2. Zub, Maciej
   3. Heumann, Asmus
   4. Hube-Magg, Claudia
   5. Simon, Ronald
   6. Lang, Dagmar S
   7. Höflmayer, Doris

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
8. Random forest-based modelling to detect biomarkers for prostate cancer progression

   1. Toth, Reka
   2. Schiffmann, Heiko
   3. Hube-Magg, Claudia
   4. Büscheck, Franziska
   5. Höflmayer, Doris
   6. Weidemann, Sören
   7. Lebok, Patrick

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
9. Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy

   1. Schroeder, Cornelia
   2. Navid-Hill, Elham
   3. Meiners, Jan
   4. Hube-Magg, Claudia
   5. Kluth, Martina
   6. Makrypidi-Fraune, Georgia
   7. Simon, Ronald

   2019 - Forschungsinformationssystem des UKE
10. Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

    1. Steurer, Stefan
    2. Schwemmer, Lara
    3. Hube-Magg, Claudia
    4. Büscheck, Franziska
    5. Höflmayer, Doris
    6. Tsourlakis, Maria Christina
    7. Clauditz, Till S

    2019 - Forschungsinformationssystem des UKE
11. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

    1. Luebke, Andreas M
    2. Attarchi-Tehrani, Ali
    3. Meiners, Jan
    4. Hube-Magg, Claudia
    5. Lang, Dagmar S
    6. Kluth, Martina
    7. Tsourlakis, Maria Christina

    2019 - Forschungsinformationssystem des UKE - frei zugänglich
12. Current Therapies of Wilms Tumors in the Adult: Diagnostic Considerations and Treatment Challenges

    1. Bradtke, Marlon
    2. Rink, Michael
    3. Büscheck, Franziska
    4. Sauter, Guido
    5. Dahlem, Roland
    6. Fisch, Margit
    7. Vetterlein, Malte W

    2019 - Forschungsinformationssystem des UKE
13. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

    1. Minner, Sarah
    2. Lutz, Jannes
    3. Hube-Magg, Claudia
    4. Kluth, Martina
    5. Simon, Ronald
    6. Höflmayer, Doris
    7. Burandt, Eike

    2019 - Forschungsinformationssystem des UKE
14. 5q21 deletion is often heterogeneous in prostate cancer

    1. Kluth, Martina
    2. Al Kilani, Zaid
    3. Özden, Cansu
    4. Hussein, Khakan
    5. Frogh, Sohall
    6. Möller-Koop, Christina
    7. Burandt, Eike

    2019 - Forschungsinformationssystem des UKE
15. Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

    1. Mandelkow, Tim
    2. Blessin, Niclas C
    3. Lueerss, Eva
    4. Pott, Laura
    5. Simon, Ronald
    6. Li, Wenchao
    7. Wellge, Björn

    2019 - Forschungsinformationssystem des UKE - frei zugänglich